References

  1. Kotila TR, Shokunbi WA. Haemoglobin F levels in healthy Nigerian adults. West Afr J Med. 2003;(22): 143-145. PubMed | Google Scholar

  2. Konotey- Ahulu ID. The sickle cell disease patient. Watford (Tettteh-A’Domeno). 1996; 25. Google Scholar

  3. Weatherall DJ. The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010;115(22):4331-4336. PubMed | Google Scholar

  4. Labie D, Richin CJ, Pagnier J, Gentilini M, Nagel RL. Hemoglobins S and C in Upper Volta. Hum Genet. 1984; 65(3):300-302. PubMed | Google Scholar

  5. Modiano D, Luoni G, Sirina BS, Simpore J, Verra F, Konate A, Rastrelli E, Oliveri A et al. Haemoglobin C protects against clinical falciparum malaria. Nature. 2001; 414 (6861):305 -308. PubMed | Google Scholar

  6. West MS, Wethers D, Smith J, Steinberg MH. Laboratory profile of sickle cell disease: a cross sectional analysis-The cooperative study of sickle cell disease . J ClinEpidemiol. 1992; 45 (8): 893 -909. PubMed | Google Scholar

  7. O’Keeffe EK, Rhodes MM, Woodworth A . A patient with a previous diagnosis of Hemoglobin S/C Disease with an unusually severe disease course. Clin Chem. 2009; 55(6):1228–1233. PubMed | Google Scholar

  8. Lamarre Y, Romana M, Waltz X, Lalanne-Mistrih M, Tressières B, Divialle-Doumdo L, Hardy-Dessources M, Vent-Schmidt J et al.Hemorheological risk factors of acute chest syndrome and painful vaso-occlusive crisis in children with sickle cell disease. Haematologica. 2012;97(11):1641-1647. PubMed | Google Scholar

  9. Lionnet F, Hammoudi N, Stojanovic KS, Avellino V, Grateau G, Girot R, Haymann JP. Hemoglobin sickle cell disease complications: a clinical study of 179 cases. Haematologica. 2012;97(8):1136-41. PubMed | Google Scholar

  10. Akinyanju OO. Sickle cell disorders .The Nigerian family practice. 1994; 1(3):24-30. PubMed | Google Scholar

  11. Ataga KI, Brittain JE, Desai P, May R, Jones S, Delaney J, Strayhorn D, Hinderliter A, Key NS. Association of coagulation activation with clinical complications in sickle celldisease. PLoS ONE. 2012; 7(1): e29786. PubMed | Google Scholar

  12. Wright JG, Malia R, Cooper P, Thomas P, Preston F, Serjeant GR. Protein C and S in homozygous sickle cell diseases: does hepatic dysfunction contribute to low levels? Br J Haematol. 1997; 98 (3):627-631. Google Scholar

  13. Mackie IJ, Kitchen S, Machin SJ, Lowe GDO and the haemostasis and thrombosis task force of the British committee for standards in haematology. Guidelines on fibrinogen assays. Br J Haematol. 2003; 121(3):396–404. PubMed | Google Scholar

  14. Famodu AA. Coagulation changes in homozygous sickle cell disease in Nigeria. J ClinPathol. 1987; 40 (12):1487. PubMed | Google Scholar

  15. Babadoko AA, Ibinaye PO, Hassan A, Yusuf R, Ijei IP, Aiyekomogbon J, Aminu SM, Hamidu AU. Autosplenectomy of sickle cell disease in Zaria, Nigeria: an ultrasonographic assessment. Oman Med J. 2012; 27(2): 121-123. PubMed | Google Scholar

  16. Fatunde OJ, Scott RB. Pitted red cell counts in sickle cell disease: relationship to age, hemoglobin genotype, and splenic size. Am J Pediatr Hematol Oncol. 1986; 8(4):329-333. PubMed | Google Scholar

  17. Famodu AA, Reid HL. Plasma fibrinogen level in sickle-cell disease. TropGeogr Med. 1987; 39(1):36-38. PubMed | Google Scholar

  18. Buseri FI, Shokunbi WA, Jeremiah ZA. Plasma fibrinogen levels in Nigerian homozygous (Hb SS) sickle cell patients. Hemoglobin. 2007; 31(1):89-92. PubMed | Google Scholar

  19. Richardson SG, Mathews KB, Stuart ,Geddes AM, Wilcox RMJ. Serial changes in coagulation and viscosity during sickle cell crisis. Br J Haematol. 1979; 41(1):95-103. PubMed | Google Scholar

  20. Omer NE, Satti MMH, Mohamed AO. Plasma level of von Willebrand factor: an indicator of severity in sickle cell disease. Sudan Journal of Medical Science. 2009; 4 (2): 123-129. PubMed | Google Scholar